mifamurtide
Sign in to saveMifamurtide (trade name Mepact, marketed by Takeda) is a drug against osteosarcoma, a kind of bone cancer mainly affecting children and young adults, which is lethal in over half of cases. The drug was approved in Europe in March 2009.
Key facts
- Drug.legal_status
- Rx
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 407798436
- Drug.IUPAC_name
- 2-[(N-{(2R)-[(2-acetamido-2,3-dideoxy-D-glucopyranos-3-yl)oxy]-propanoyl}-L-alanyl-D-isoglutaminyl-L-alanyl)amino]ethyl (2R)-2,3-bis(hexadecanoyloxy)propyl hydrogen phosphate
- Drug.image
- Mifamurtide.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 300
- Drug.tradename
- Mepact
- Drug.licence_EU
- yes
- Drug.pregnancy_category
- not investigated
- Drug.routes_of_administration
- intravenous liposomal infusion over one hour
- Drug.bioavailability
- N/A
- Drug.elimination_half life
- minutes (in plasma)18 hrs (terminal)
- Drug.CAS_number
- 83461-56-7
- Drug.CAS_supplemental
- (mifamurtide sodium)
- Drug.ATC_prefix
- L03
- Drug.ATC_suffix
- AX15
via Wikipedia infobox
Wikidata facts
- Mass
- 1236.7485118980003
Show 4 more facts
- isomeric SMILES
- CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCNC(=O)[C@H](C)NC(=O)CC[C@H](C(=O)N)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@@H]([C@H](OC([C@@H]1NC(=O)C)O)CO)O)OC(=O)CCCCCCCCCCCCCCC
- canonical SMILES
- CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCNC(=O)C(C)NC(=O)CCC(C(=O)N)NC(=O)C(C)NC(=O)C(C)OC1C(C(OC(C1O)CO)O)NC(=O)C)OC(=O)CCCCCCCCCCCCCCC
- chemical formula
- C₅₉H₁₀₉N₆O₁₉P
- defined daily dose
- 0.7
Sources (3)
via Wikidata · CC0
~7 min read
Article
10 sectionsContents
- Medical uses
- Adverse effects
- Interactions
- Pharmacology
- Mechanism of action
- Pharmacokinetics
- Chemistry
- Synthesis
- History
- References
{{Infobox drug | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 407798436 | IUPAC_name = 2-[(N-{(2R)-[(2-acetamido-2,3-dideoxy-D-glucopyranos-3-yl)oxy]-propanoyl}-L-alanyl-D-isoglutaminyl-L-alanyl)amino]ethyl (2R)-2,3-bis(hexadecanoyloxy)propyl hydrogen phosphate | image = Mifamurtide.svg | image_class = skin-invert-image | width = 300
| tradename = Mepact | licence_EU = yes | pregnancy_AU = | pregnancy_US = | pregnancy_category = not investigated | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = Rx | routes_of_administration = intravenous liposomal infusion over one hour
Gallery (3)
Available in 10 languages
via Wikidata sitelinks · CC0